Presbyterian Medical Center

Renal artery stenosis


iCast™ RX De Novo Stent Placement for the Treatment of Atherosclerotic Renal Artery Stenosis in Patients with Resistant Hypertension

Principle Investigator: Dr. Michael Miller

What is the purpose of the study?

The primary objective of the ARTISAN trial is to evaluate the safety and efficacy of the iCAST™ RX Stent System for the treatment of subjects with resistant hypertension associated with de novo atherosclerotic renal artery disease.

Who is eligible?

Patients who are candidates for a renal artery revascularization with > 80% visual stenosis and have resistant hypertension with > 155 mmHg while on > anti-hypertensive medications from at least 3 distinct classes of drugs.  The patient must meet all inclusion and none of the exclusion criteria required by the study.

For more information, contact:

Dr. Michael Miller
Phone: 704-264-1400

Link to the current record »